Target intelligence / Profile preview

Ring finger protein 7 (RNF7)

Target
RNF7
Molecular classification
E3 ubiquitin ligase (RING-type), Zinc finger protein, Enzyme
01

Overview

Ring finger protein 7 (RNF7) is a highly conserved zinc finger protein that acts as an essential subunit of cullin-RING E3 ubiquitin ligase complexes (notably CRLs/SCF). RNF7 mediates the ubiquitination and subsequent proteasomal degradation of a wide array of regulatory proteins, including cell cycle inhibitors (such as p21 and p27) and pro-apoptotic factors, influencing key cellular processes like cell cycle progression, apoptosis, and signal transduction. RNF7 also possesses antioxidant functions, being inducible by redox stimuli and helping neutralize reactive oxygen species. Dysregulation and overexpression of RNF7 are linked to tumor progression, therapy resistance, and poor prognosis in several cancers, making it a promising candidate for therapeutic intervention and biomarker development[1][2][3][5][7].

Other names
RING-box protein 2RBX2ROC2SAGCKBBP1CKII beta-binding protein 1Regulator of cullins 2Sensitive to apoptosis gene proteinSensitive to apoptosis zinc RING finger protein SAG
02

Mechanism of action

Inhibition or silencing of RNF7 upregulates tumor suppressor proteins (e.g., p21, p27, NOXA), inactivates ERK1/2 and NF-κB pathway, suppresses proliferation and increases chemosensitivity[2][4]. As an E3 ligase, RNF7 catalyzes ubiquitination and proteasomal degradation of numerous substrate proteins, regulating cell fate.

03

Biological functions

Protein ubiquitinationCell cycle regulationSignal transductionApoptosis regulationRedox regulation/antioxidant responseDNA replication and repair modulationRegulation of NF-κB signaling
04

Disease associations

CancerInflammationLiver fibrosisGlomuvenous malformationsRenal cell carcinoma
05

Safety considerations

Therapeutic inhibition may affect essential protein homeostasis, potentially causing dysregulated cell cycle and apoptosis in normal cellsOff-target effects due to involvement in multiple cellular pathways and broad substrate spectrum
06

Interacting drugs

Sunitinib

1 more in the full profile.

07

Biomarkers

RNF7 expression (tumor tissue, particularly prostate, lung, colon, stomach, liver cancers)[2][1]RNF7 gene polymorphisms (liver fibrosis risk in hepatitis C patients)[1]

Beyond the preview

Go deeper on Ring finger protein 7 (RNF7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ring finger protein 7 (RNF7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call